Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
481 - 490 out of 508Page size: 10
  1. 2014
  2. Published

    Cause-Specific Mortality According to Urine Albumin Creatinine Ratio in the General Population

    Skaaby, T., Husemoen, L. L. N., Ahluwalia, Tarun Veer Singh, Rossing, Peter, Jørgensen, T., Thuesen, B. H., Pisinger, C., Rasmussen, K. & Linneberg, Allan René, 2014, In: PLOS ONE. 9, 3, p. 1-10 10 p., e93212.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. 2013
  4. Published

    Clinical use of estimated glomerular filtration rate for evaluation of kidney function.

    Broberg, B., Lindhardt, M., Rossing, Peter, Ibsen, H., Persson, F. & Rasmussen, K., 30 Sep 2013, In: Ugeskrift for Laeger. 175, 40, p. 2333-2336 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Diabetes mellitus, hypertension and albuminuria in rural Zambia: a hospital-based survey

    Rasmussen, J. B., Thomsen, J. A., Rossing, Peter, Parkinson, S., Christensen, Dirk Lund & Bygbjerg, Ib Christian, Sep 2013, In: Tropical Medicine & International Health. 18, 9, p. 1080-4 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    RNA oxidation and albuminuria in type 1 diabetes patients

    Broedbaek, K., Andersen, Jon Thor Trærup, Solem, Espen Victor Jimenez, Petersen, M., Lajer, M., Henriksen, T., Weimann, A., Parving, H. H., Rossing, Peter & Poulsen, Henrik Enghusen, 2013, In: Cardiovascular Endocrinology. 2, 4, p. 103-105 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. 2011
  8. Published

    Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes

    Cangemi, C., Skov, V., Poulsen, M. K., Funder, J., Twal, W. O., Gall, M., Hjortdal, Vibeke Elisabeth, Jespersen, M. L., Kruse, T. A., Aagard, J., Parving, H., Knudsen, S., Høilund-Carlsen, P., Rossing, Peter, Henriksen, J. E., Argraves, W. S. & Rasmussen, L. M., Nov 2011, In: Clinical Chemistry. 57, 11, p. 1556-65 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Endothelial Progenitor Cells in Long-Standing Asymptomatic Type 1 Diabetic Patients with or without Diabetic Nephropathy

    Reinhard, H., Jacobsen, P. K., Lajer, M., Tarnow, L., Astrup, A. S., Kim, W. Y., Pedersen, N., Billestrup, Nils, Mandrup-Poulsen, Thomas, Parving, H. & Rossing, Peter, 2011, In: Nephron Clinical Practice. 118, 3, p. c309-c314 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria

    Reinhard, H., Nybo, M., Hansen, Peter Riis, Wiinberg, N., Kjær, Andreas, Petersen, C. L., Winther, Kaj, Parving, H., Rasmussen, L. M., Rossing, Peter & Jacobsen, P., 2011, In: Cardiovascular Diabetology. 10, p. 70

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. 2010
  12. Published

    Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes

    Reinhard, H., Jacobsen, P. K., Lajer, M., Pedersen, N., Billestrup, Nils, Mandrup-Poulsen, Thomas, Parving, H. & Rossing, Peter, 1 Oct 2010, In: Diabetologica. 53, 10, p. 2129-33 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis

    Hansen, H. G., Overgaard, J., Lajer, M., Hubalek, F., Højrup, P., Pedersen, L., Tarnow, L., Rossing, Peter, Pociot, Flemming & McGuire, J. N., 1 Sep 2010, In: Proteomics - Clinical Applications. 4, 8-9, p. 697-705 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    LONG-TERM EFFECTS OF IRBESARTAN TREATMENT AND SMOKING ON NUCLEIC ACID OXIDATION IN PATIENTS WITH TYPE 2 DIABETES AND MICROALBUMINURIA.

    Brodbaek, K., Henriksen, T., Weimann, A., Petersen, M., Andersen, J. T., Afzal, Shoaib, Solem, E. J., Rossing, Peter & Poulsen, Henrik Enghusen, Sep 2010, In: Journal of Clinical Pharmacology. 50, 9, p. 1076-1076 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Previous 1...45 46 47 48 49 50 51 Next

ID: 12937790